Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Sofie Biosciences in August, 2018 for $1,002,432.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44EB023782-02A1 | Phase II | 1,002,432 | August 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Sofie Biosciences in August, 2012 for $995,467.0 USD from the U.S. Department of Energy. | SBIR | DE-FG02-11ER90136 | Phase II | 995,467 | August 8, 2012 | |||||||
A SBIR Phase II contract was awarded to Sofie Biosciences in September, 2017 for $1,997,079.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA216539-02 | Phase II | 1,997,079 | September 7, 2017 | |||||||
A SBIR Phase I contract was awarded to Sofie Biosciences in June, 2011 for $150,000.0 USD from the U.S. Department of Energy. | SBIR | DE-FG02-11ER90136 | Phase I | 150,000 | June 17, 2011 | |||||||
A SBIR Phase II contract was awarded to Sofie Biosciences in September, 2013 for $1,777,601.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH097271-02 | Phase II | 1,777,601 | September 25, 2013 | |||||||
A SBIR Phase II contract was awarded to Sofie Biosciences in August, 2017 for $1,999,603.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH097271-05 | Phase II | 1,999,603 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Sofie Biosciences in September, 2016 for $149,800.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB023782-01 | Phase I | 149,800 | September 12, 2016 | |||||||
A SBIR Phase I contract was awarded to Sofie Biosciences for $145,210.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH097271-01 | Phase I | 145,210 | ||||||||
A SBIR Phase II contract was awarded to Sofie Biosciences for $1,492,762.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO140041 | Phase II | 1,492,762 | ||||||||
A SBIR Phase I contract was awarded to Sofie Biosciences for $250,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120053 | Phase I | 250,000 |